Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jul;85(1):3-5.
doi: 10.4269/ajtmh.2011.11-0160.

Ivermectin mass drug administration to humans disrupts malaria parasite transmission in Senegalese villages

Affiliations

Ivermectin mass drug administration to humans disrupts malaria parasite transmission in Senegalese villages

Kevin C Kobylinski et al. Am J Trop Med Hyg. 2011 Jul.

Abstract

Ivermectin mass drug administration (MDA) to humans is used to control onchocerciasis and lymphatic filariasis. Recent field studies have shown an added killing effect of ivermectin MDA against malaria vectors. We report that ivermectin MDA reduced the proportion of Plasmodium falciparum infectious Anopheles gambiae sensu stricto (s.s.) in treated villages in southeastern Senegal. Ivermectin MDA is a different delivery method and has a different mode of action from current malaria control agents. It could be a powerful and synergistic new tool to reduce malaria transmission in regions with epidemic or seasonal malaria transmission, and the prevalence and intensity of neglected tropical diseases.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Field site map. Topographical map of the five villages where the experiment was conducted in 2008 and 2009.
Figure 2.
Figure 2.
The proportion of Plasmodium falciparum infectious Anopheles gambiae s.s. before and after ivermectin MDAs. The mean percent of P. falciparum sporozoite-infectious An. gambiae s.s. were estimated from three replicate collections of mosquitoes in treated and pair-matched untreated, control villages in southeastern Senegal. Filled (•) and open (○) circles represent the means of ivermectin treated and untreated control villages, respectively. Error bars represent 95% confidence intervals.

References

    1. Hay SI, Okiro EA, Gething PW, Patil AP, Tatem AJ, Guerra CA, Snow RW. Estimating the global clinical burden of Plasmodium falciparum malaria in 2007. PLoS Med. 2010;7:e1000290. - PMC - PubMed
    1. Snow RW, Craig M, Deichmann U, Marsh K. Estimating mortality, morbidity and disability due to malaria among Africa's non-pregnant population. Bull World Health Organ. 1999;77:624–640. - PMC - PubMed
    1. The malERA Consultative Group on Vector Control A research agenda for malaria eradication: vector control. Plos Med. 2011;8:e1000401. - PMC - PubMed
    1. WHO . Malaria vector control and personal protection. WHO technical report series: no. 936. Geneva: WHO; 2006. - PubMed
    1. Amazigo U. The African Programme for Onchocerciasis Control (APOC) Ann Trop Med Parasitol. 2008;102:19–22. - PubMed

Publication types